Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06307275

Intermittent Fasting on Body Fat and Quality of Life

The Effect of Intermittent Fasting on Body Fat and Quality of Life

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life.

Detailed description

Start of study: Informed Consent, Body Fat Analysis, Questionnaires on quality of life, sleep, and stress. For the next four weeks, participants will eat their normal food intake with no restrictions on when to eat. Participants will keep their normal weekly exercise routine. Midway of study: Body Fat Analysis, Questionnaires on quality of life, sleep, and stress. For the next four weeks, participants will do the intermittent fasting program. This program has participants fasting 16 hours from their last meal of the previous evening's meal to the first meal of their next day. Then for 8 hours, participants are able to eat. During the fasting, participants are allowed to consume water and black coffee/tea. Participants will also keep their normal weekly exercise routine. End of study: Body Fat Analysis, Questionnaires on quality of life, sleep, and stress.

Conditions

Interventions

TypeNameDescription
OTHERFastingFasting for 16 hours from participant last meal of the previous evening's meal to the first meal of the next day. Then for 8 hours, participant is able to eat. During the fasting, participants are allowed to consume water and black coffee/tea. Participants will also keep their normal weekly exercise routine.
OTHERnon fastingParticipants will not be fasting during these four weeks. They will eat their normal food intake and keep their normal physical activity levels.

Timeline

Start date
2024-03-11
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-03-12
Last updated
2025-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06307275. Inclusion in this directory is not an endorsement.